#162441

Anti-CAR Whitlow Linker [1C3C3]

Cat. #162441

Anti-CAR Whitlow Linker [1C3C3]

Cat. #: 162441

Unit size: 1 mg

Target: Chimeric antigen receptor Whitlow scFv peptide linker

Class: Monoclonal

Application: Flow cytometry, IHC, stimulation of T cells

Host: Mouse

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Erik Kimble, Jocelyn Wright

Institute: Fred Hutchinson Cancer Center

Primary Citation: Kimble et al. 2025.J Immunother Cancer. 2025 Nov 18;13(11):e013123. PMID: 41253500

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CAR Whitlow Linker [1C3C3]
  • Clone: 1C3C3
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Host: Mouse
  • Application: Flow cytometry, IHC, stimulation of T cells
  • Description: The anti-CAR Whitlow linker peptide 1C3C3 clone has been developed to detect cells expressing Whitlow linker-containing CARs with different antigen specificities, including those harbouring the widely employed anti-CD19 FMC63-derived scFv as well as other scFvs, such as those targeting B-cell maturation antigen (BCMA) or CD33. It has been demonstrated to have a mean KD of 1 to 2.6 µM when tested for binding kinetics against FMC63-Whitlow scFv protein and the Whitlow peptide. No binding to G4S4 peptide was found. In addition, the 1C3C3 antibody has been demonstrated to stain engineered T cells expressing 1H7- or FMC63-Whiltow, but not 1H7- or FMC63- G4S4 by FACS analysis.
  • Immunogen: Synthetic Whitlow peptide
  • Isotype: IgG2a

Target Details

  • Target: Chimeric antigen receptor Whitlow scFv peptide linker
  • Target background: While CAR T-cell therapies have revolutionized the treatment of B-lineage malignancies, high-resolution tracking of CAR-engineered cells within the tumor microenvironment (TME) remains a significant technical challenge, particularly in archival formalin-fixed paraffin-embedded (FFPE) tissues. To address this, murine monoclonal antibodies (mAbs) have been developed to specifically target the Whitlow linker, a synthetic peptide commonly utilized in the scFv domains of multiple FDA-approved CAR products (e.g., axi-cel, liso-cel). Because this linker is absent in native human tissue and conserved across various antigen specificities, these mAbs provide a universal tool for the in situ identification, selection, and functional analysis of CAR-expressing cells. This methodology enables a more precise evaluation of CAR T-cell infiltration, persistence, and correlation with clinical outcomes or toxicities.

Applications

  • Application: Flow cytometry, IHC, stimulation of T cells

Handling

  • Unit size: 1 mg

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.